Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Eton Pharmaceuticals, Inc. (ETON) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ETON at 67.5/100 on a 32-signal composite quality model, placing it at rank #364 of 2,961 stocks — the top 25% of the AI-ranked universe. ETON scores in the top quartile across revenue growth (95.5), balance sheet strength (88.4), profitability (75.3). Areas of concern include revenue scale (16.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Eton Pharmaceuticals, Inc. reports quarterly revenue of $37.6M, net income of $11.6M, free cash flow of $7.3M. Top institutional holders of ETON by reported 13-F value include Opaleye Management, EcoR1 Capital, BlackRock, based on the most recent SEC filings. ETON trades on the Nasdaq exchange and files with the SEC under CIK 1710340. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ETON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Eton Pharmaceuticals, Inc. directly from SEC EDGAR.
AI Quality Score
67.5/100
AI Rank
#364
Revenue
$37.6M
Net Income
$11.6M
Free Cash Flow
$7.3M
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $80.0M | $-4.6M | -1.1% |
| FY 2024 | 10-K | $39.0M | $-3.8M | -6.7% |
| FY 2023 | 10-K | $31.6M | $-936.0K | -3.8% |
| FY 2022 | 10-K | $21.3M | $-9.0M | -38.9% |
| FY 2021 | 10-K | $21.8M | $-2.0M | -6.9% |
| FY 2020 | 10-K | $39.0K | $-28.0M | — |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| Opaleye Management | 2,860,000 | $103.5M | 2026-06-30 |
| EcoR1 Capital | 2,171,938 | $78.6M | 2026-06-30 |
| BlackRock | 1,895,833 | $68.6M | 2026-06-30 |
| Nantahala Capital Management | 1,175,951 | $42.6M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 976,570 | $35.4M | 2026-06-30 |
| MORGAN STANLEY | 767,972 | $27.8M | 2026-06-30 |
| STATE STREET | 701,786 | $25.4M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT | 652,303 | $23.6M | 2026-06-30 |
| OBERWEIS ASSET MANAGEMENT | 501,600 | $18.2M | 2026-06-30 |
| National Philanthropic | 492,112 | $17.8M | 2026-06-30 |